Literature DB >> 19002614

Gene and protein expression of p53 and p21 in fibroadenomas and adjacent normal mammary tissue.

Lolita Schneider1, Gisele Branchini, Rodrigo Cericatto, Edison Capp, Ilma Simoni Brum.   

Abstract

The aim of this study was to compare p53 and p21 mRNA, and proteins levels between fibroadenomas and adjacent normal mammary tissue of women in reproductive age. A transversal study was performed. Fourteen patients who attended the Breast Service of the Hospital de Clínicas de Porto Alegre were assessed and submitted to surgical resection of fibroadenomas. Fragments of the central area of the fibroadenoma and adjacent normal mammary tissue were obtained. mRNA expression for genes p53 and p21 was evaluated by RT-PCR, and protein expression by the western blot. Paired analyses showed higher gene expression of p53 (P = 0.017) and p21 (P = 0.003), and a higher protein expression of p53 (P = 0.001) in fibroadenomas as compared to normal breast tissue. p21 protein expression was not different (P = 0.97) between the fibroadenoma and the adjacent normal mammary tissue samples. These results suggest the participation of p53 in the formation of fibroadenomas. The role of p21 in fibroadenomas remains to be defined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19002614     DOI: 10.1007/s12020-008-9124-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  25 in total

Review 1.  Apoptosis and aging: breast cells and apoptosis.

Authors:  A Gompel; D Levy; M Chaouat; P Forgez; W Rostène
Journal:  Maturitas       Date:  2001-02-28       Impact factor: 4.342

2.  Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas.

Authors:  S La Rosa; F Sessa; L Colombo; M G Tibiletti; D Furlan; C Capella
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 3.  The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.

Authors:  Andrei L Gartel; Angela L Tyner
Journal:  Mol Cancer Ther       Date:  2002-06       Impact factor: 6.261

4.  P53 expression in patients with malignant and benign breast diseases.

Authors:  A Kalogeraki; J Panayiotides; D Tamiolakis; M Tzardi; V Chaniotis; G Chalkiadakis; J Melissas; D Stiftsis; P Kanavaros; G S Delides
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

5.  Wild-type p53 can inhibit oncogene-mediated focus formation.

Authors:  D Eliyahu; D Michalovitz; S Eliyahu; O Pinhasi-Kimhi; M Oren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Induction of p21 (WAF-1/CIP1) during differentiation.

Authors:  R A Steinman; B Hoffman; A Iro; C Guillouf; D A Liebermann; M E el-Houseini
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

7.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

Authors:  M H Lee; I Reynisdóttir; J Massagué
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

8.  Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium.

Authors:  C N Robson; V Gnanapragasam; R L Byrne; A T Collins; D E Neal
Journal:  J Endocrinol       Date:  1999-02       Impact factor: 4.286

9.  Androgen-dependent expression of c-jun and c-fos in human non-transformed epithelial prostatic cells: association with cell proliferation.

Authors:  Ilma S Brum; Débora M Morsch; Adriane Pozzobon; Valderes A Boeri; Guilherme Geib; Poli Mara Spritzer
Journal:  Horm Res       Date:  2003

Review 10.  The pathology of familial breast cancer: Immunohistochemistry and molecular analysis.

Authors:  P P Osin; S R Lakhani
Journal:  Breast Cancer Res       Date:  1999-10-27       Impact factor: 6.466

View more
  1 in total

1.  Progesterone receptors A and B and estrogen receptor alpha expression in normal breast tissue and fibroadenomas.

Authors:  Gisele Branchini; Lolita Schneider; Rodrigo Cericatto; Edison Capp; Ilma Simoni Brum
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.